This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Korea Atomic Energy Research Institute. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Yeon Jee Kahm: Innovator in Cancer Treatment
Introduction
Yeon Jee Kahm is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.
Latest Patents
Yeon Jee Kahm holds a patent for an "Anti-TM4SF4 antibody and uses thereof." This invention relates to antibodies or antigen-binding fragments that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies exhibit proliferation inhibitory activity against cancer cells, effectively preventing or treating cancer. They also reduce the self-renewal ability of cancer stem cells, making them useful in treating cancers with poor prognoses in conventional anticancer treatments. He has 1 patent to his name.
Career Highlights
Yeon Jee Kahm is affiliated with the Korea Atomic Energy Research Institute, where he conducts his research. His work focuses on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
He collaborates with notable colleagues, including In Gyu Kim and Rae Kwon Kim, to advance his research and enhance the effectiveness of cancer treatments.
Conclusion
Yeon Jee Kahm's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical science and patient care.